NAVPITPTLNR

NAVPITPTLNR, a casein-derived peptide, is an angiotensin I‐converting enzyme (ACE) inhibitor. NAVPITPTLNR can be used for hypertension research[1].

123432-25-7

12352209

Angiotensin-converting Enzyme (ACE)

Metabolic Enzyme/Protease

Cardiovascular Disease

O=C(N[C@@H](C)C(N[C@@H](C(C)C)C(N1[C@@H](CCC1)C(N[C@@H]([C@@H](C)CC)C(N[C@@H]([C@H](O)C)C(N2[C@@H](CCC2)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CCCNC(N)=N)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(N)=O)N

C52H90N16O16

1195.37

[1]De Oliveira T V, et al. Casein-Derived Peptides with Antihypertensive Potential: Production, Identification and Assessment of Complex Formation with Angiotensin I-Converting Enzyme (ACE) through Molecular Docking Studies. Food Biophysics 2019, 15 (2), 162-172.

Room temperature

http://file.medchemexpress.com/batch_PDF/HY-P11572/

Peptides

No Development Reported